- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06910800
Indwelling Pleural Catheters: a Self-management Intervention (PACMAN)
Indwelling Pleural Catheters: Co-developing an Intervention to Support Self-Management
A pleural effusion is a build-up of fluid around the lung. In the UK, about quarter of a million people develop a pleural effusion each year. They are usually caused by advanced cancer or heart, kidney, or liver failure. People with a pleural effusion feel breathless and can't do the things they want to. Draining the fluid improves breathlessness and quality of life. This can be done by inserting a semi-permanent tube called an indwelling pleural catheter (IPC). This is drained at home about three times a week.
Drainage is usually done by a community nurse. However, it can be done by the patient or family/unpaid carers - this is called self-management. Self-management gives the patient the freedom to drain their IPC when they need to, without having to wait at home until a nurse is available. It reduces the burden on community nursing services. Despite these benefits, not all patients get the opportunity to self-manage.
The aim of this study is to help more patients self-manage if they want to. We will achieve this through three stages:
Stage 1: We will talk to patients with IPCs as well as their families/carers to find out their views on self-management and what stops people who could self-manage from doing so. We know that patients with an IPC can be frail. Often their families/carers are already doing a lot to support them. We will ask what might help them to self-manage if they would like to.
Stage 2: We will talk to healthcare professionals (HCPs) looking after patients with IPCs to understand what they think about self-management. This will include community nurses and the hospital teams who put IPCs in.
Stage 3: Along with our patients, their families/unpaid carers and HCPs, we will hold workshops to design an intervention that will help people to self-manage IPCs. We don't know what this intervention will look like yet. From talking to patients and families who already self-manage, we have found they like to learn from a demonstration on their own IPC followed by supervised self-management until they feel confident. Therefore, our intervention may include training sessions for HCPs on how to teach self-management.
This study grew from conversations with our patients. People with an IPC, family members and community nurses helped design the study. Our patient and public involvement (PPI) group will help design study materials and guide the study.
Study Overview
Status
Conditions
Detailed Description
Research question:
How can patients with an indwelling pleural catheter (IPC) and their family/unpaid carers be supported to self-manage?
Background:
Pleural effusion is the accumulation of fluid in the space between the lung and chest wall. It is a common complication of malignancy and affects approximately 200-250,000 people annually in the UK. People with such an effusion experience disabling breathlessness; this is treated by draining the fluid using IPCs (semi-permanent chest drains). These are usually managed at home by community nurses, but this can be done by the patient, family member or carer. Supported self-management is part of the NHS long term plan and British Thoracic Society guidelines state that patients should be supported to self-manage their IPC to promote independence. However, there is no evidence to support these recommendations, nor guidance on how self-management should be facilitated. There is thus an evidence gap at the heart of current recommendations.
Objectives:
O1. Identify support needs of patients with IPCs and their family/unpaid carers and how these impact on the acceptability and feasibility of self-management.
O2. Identify barriers and motivators to IPC self-management among patients and family/unpaid carers.
O3. Understand healthcare professional (HCP) attitudes toward, and practices related to, IPC self-management.
O4. Co-design and develop an evidence-based intervention to facilitate IPC self-management.
Methods:
An applied qualitative study and co-design project comprising three stages mapped to the four objectives.
S1: semi-structured interviews with patients with an IPC and their family/unpaid carers regarding self-management and support needs.
S2: focus groups and interviews with community nurses and IPC service staff regarding self-management.
S3: co-design and development of a self-management intervention.
Interviews will be audio- or audiovisual-recorded (with permission), transcribed, and analysed using thematic analysis. Codes will be assigned to text to categorise meanings. Given the lack of prior research, the coding schema will be developed inductively from early transcripts (with reference to literature from other fields), refined and applied to subsequent transcripts. Codes will be categorised, themes identified, and the results developed into a narrative. The COM-B system will be the model of reference for the development of the self-management intervention. This is comprised of a behaviour change wheel linked to intervention functions and policy categories.
Inclusion criteria Stage 1 - patients and family/unpaid carers
- Adult (>18 years) who has (or has had) an IPC OR
- Adult family member or unpaid carer of a patient who has (or has had) an IPC
- Patients may currently be self-managing or receiving CN care. Stage 2 - healthcare professionals
- Community nurse: experience of caring for a patient with an IPC within the last 12 months and signed-off as competent in IPC management
- IPC-insertion site staff: any HCP involved in discussion with patients about post-insertion IPC care Stage 3 - co-design groups
- as above
Exclusion criteria Stage 1 - patients
- Patient with a life expectancy of less than 6 weeks
- Patient or family/unpaid carer who lacks capacity to offer informed consent (as judged by a suitably qualified HCP in accordance with Good Clinical Practice guidelines) Stage 2 - Health care professionals
- None Stage 3 - co-design groups
- As above
Anticipated Impact and Dissemination
The principal output will be a prototype self-management intervention for patients with an IPC and their family/unpaid carers that will:
- Empower patients, increase perceived symptom control, and reduce time spent 'waiting in' for nursing visits;
- Relieve pressure on community nursing services and reduce healthcare costs;
- Support the NHS long term plan by enabling supported self-management;
- Facilitate more frequent drainage which may prevent re-accumulation of pleural fluid.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Locations
-
-
Norfolk
-
Norwich, Norfolk, United Kingdom, NR4 7UY
- Norfolk and Norwich University Hospitals NHS Trust
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
Stage 1 - Patients and family/unpaid carers
- Adult (>18 years) who has (or has had) an IPC OR
- Adult family member or unpaid carer of a patient who has (or has had) an IPC
- Patients may currently be self-managing or receiving CN care.
Stage 2 - Healthcare professionals
- Community nurse: experience of caring for a patient with an IPC within the last 12 months and signed-off as competent in IPC management
- IPC-insertion site staff: any HCP involved in discussion with patients about post-insertion IPC care
Stage 3 - Co-design groups
o as above
Exclusion Criteria:
Stage 1 - Patients
- Patient with a life expectancy of less than 6 weeks
- Patient or family/unpaid carer who lacks capacity to offer informed consent (as judged by a suitably qualified HCP in accordance with Good Clinical Practice guidelines)
Stage 2 - Health care professionals o None
Stage 3 - Co-design groups
o As above
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Patients
Patients who have (or have had) an IPC.
|
|
Family members and unpaid carers
Family members and unpaid carers of patients who have (or have had) an IPC.
|
|
Healthcare professionals
Community nurses involved in IPC care and healthcare professionals involved in IPC insertion.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Capturing Health Care Professionals attitudes toward and beliefs about self-management
Time Frame: Periprocedural
|
Data will be collected via focus groups and interviews. The different data collection designs reflect the nature of how the two groups of HCPs work and working patterns. The topic guide for the two activities will thus be largely the same and given the common subject matter it will be possible to analyse the qualitative data from these two approaches together. There will be some additional, group-specific, questions reflecting the different roles these two HCP groups play in the patient care pathway. The four objectives to achieve this are:
|
Periprocedural
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Adam M Dr Peel, Norfolk and Norwich University Hospitals NHS Trust
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- Pac-man protocol | v1.0 | 14.0
- 333923 (Registry Identifier: IRAS)
- 58382 (Registry Identifier: CPMS)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
Stakeholders including - but not limited to:
- Regional integrated care boards, and participating NHS trusts / study recruitment sites.
- Influential third sector organisations such as Mesothelioma UK
- IPC manufacturers
- Relevant charities such as Breast Cancer UK and the Roy Castle lung cancer foundation.
- Via the FutureNHS platform.
- Members of the BTS Pleural Guideline Development group
IPD Sharing Supporting Information Type
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Indwelling Pleural Catheter
-
B. Braun Ltd. Centre of Excellence Infection ControlTerminatedComplications; Catheter, Urinary (Indwelling Catheter) (Suprapubic)Belgium, Germany, Switzerland
-
Guy's and St Thomas' NHS Foundation TrustCompletedMalignant Pleural Effusion | Indwelling Pleural CatheterUnited Kingdom
-
Bulent Ecevit UniversityCompleted
-
TriHealth Inc.TerminatedObstruction; Catheter, Infusion Catheter (Vascular) | Catheter; Complications (Indwelling Catheter)United States
-
TriHealth Inc.CompletedObstruction; Catheter, Infusion Catheter (Vascular) | Catheter; Complications (Indwelling Catheter)United States
-
West China HospitalCompleted
-
Istanbul University - CerrahpasaNot yet recruitingUrologic Surgery | Catheter Associated Urinary Tract Infection | Indwelling Urinary CatheterTurkey (Türkiye)
-
University of SouthamptonBlueWind Medical; University Hospital Southampton NHS Foundation Trust; National...WithdrawnIndwelling Urinary Catheter UsersUnited Kingdom
-
Linkoeping UniversityCompletedCatheter-Related Infections | Catheters, IndwellingSweden
-
Rethink Medical SLEvidenze Health España (CRO); Centro para el Desarrollo Tecnológico y la Innovación...SuspendedQuality of Life | Catheter; Infection (Indwelling Catheter) | Catheter Related ComplicationPortugal, Spain